Login / Signup

Generation and Characterization of Site-Specifically Mono-Ubiquitylated p53.

Alexandra JulierVanessa RadtkeAndreas MarxMartin Scheffner
Published in: Chembiochem : a European journal of chemical biology (2022)
The tumor suppressor p53 is regulated by various posttranslational modifications including different types of ubiquitylation, which exert distinct effects on p53. While modification by ubiquitin chains targets p53 for degradation, attachment of single ubiquitin moieties (mono-ubiquitylation) affects the intracellular location of p53 and/or its interaction with chromatin. However, how this is achieved at the molecular level remains largely unknown. Similarly, since p53 can be ubiquitylated at different lysine residues, it remains unclear if the eventual effect depends on the position of the lysine modified. Here, we combined genetic code expansion with oxime ligation to generate p53 site-specifically mono-ubiquitylated at position 120. We found that mono-ubiquitylation at this position neither interferes with p53 ubiquitylation by the E3 ligases HDM2 and E6AP in complex with the viral E6 oncoprotein nor affects p53 binding to a cognate DNA sequence. Thus, ubiquitylation per se does not affect physiologically relevant properties of p53.
Keyphrases
  • transcription factor
  • small molecule
  • genome wide
  • gene expression
  • sars cov
  • amino acid
  • circulating tumor
  • copy number